UBS, Secures

UBS Secures Key Regulatory Milestone for US Banking Operations

19.01.2026 - 06:26:05 | boerse-global.de

UBS CH0244767585

UBS Secures Key Regulatory Milestone for US Banking Operations - Foto: über boerse-global.de
UBS Secures Key Regulatory Milestone for US Banking Operations - Foto: über boerse-global.de

UBS Group AG has achieved a significant regulatory advancement that could fundamentally reshape its competitive standing in the world's largest wealth management market. The Office of the Comptroller of the Currency (OCC) granted an initial provisional approval for a National Bank Charter on January 15, 2026. This critical step moves the Swiss banking giant closer to becoming the first bank from Switzerland to obtain a full US banking license.

Obtaining a full license would allow UBS to dramatically broaden its service portfolio for affluent clients in the United States. The bank could offer checking and savings accounts alongside mortgage products directly, providing a substantial competitive edge in the pursuit of high-net-worth individuals. A company spokesperson described the OCC's decision as a pivotal milestone on the path to final authorization.

This development has been viewed positively by equity researchers. J.P. Morgan reaffirmed its "Overweight" rating on UBS shares. Similarly, analysts at Deutsche Bank maintained a "Buy" recommendation on the stock as of January 14.

Key Developments to Watch:
* Provisional US full banking license approved.
* Final regulatory authorization anticipated in 2026.
* Quarterly earnings scheduled for release on February 4, 2026.
* Analyst sentiment remains positive.

Should investors sell immediately? Or is it worth buying UBS?

Domestic Regulatory Challenges Emerge

Even as UBS pursues its expansion in North America, it faces increasing regulatory scrutiny in its home market. The bank has publicly criticized proposed new capital rules from the Swiss Federal Council, labeling them "disproportionate." The regulations in question could, if implemented, require UBS to fully back its foreign subsidiaries with substantial equity capital. The bank estimates this could create an additional capital requirement of up to $23 billion.

Integration Progress and Leadership Timeline

The bank continues to advance the complex integration of Credit Suisse. A further wave of job reductions is planned to commence in mid-January 2026.

Investor attention is also turning to the upcoming fourth-quarter 2025 results, due on February 4, 2026. Market participants are anticipating details on planned capital returns to shareholders, which may include share buyback programs and a potential dividend increase.

Regarding leadership, CEO Sergio Ermotti has confirmed his intention to step down following the completion of the Credit Suisse integration, which is projected for early 2027. The question of succession is gaining prominence, with internal candidates considered the current frontrunners.

Ad

UBS Stock: Buy or Sell?! New UBS Analysis from January 19 delivers the answer:

The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 19.

UBS: Buy or sell? Read more here...

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>

Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.

CH0244767585 | UBS | boerse | 68499144 |